CRP and chronic obstructive pulmonary disease: Many inflammatory biomarkers (e.g., CRP, fibrinogen, etc.)are related to a higher risk of COPD exacerbation and cardiovascular event and can be used to determine the risk of both diseases and assess response to treatment.